AOBI — American Oriental Bioengineering Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for American Oriental Bioengineering, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2008 December 31st	C2009 December 31st	C2010 December 31st	2011 December 31st	2012 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	47.1	41.3	14.1	-68.5	-59.7
Depreciation
Deferred Taxes
Non-Cash Items	16	1.83	5.24	79.6	7.66
Unusual Items
Purchased R&D
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	0.61	-27	-23.4	12.2	-7.17
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities	74.8	27.6	8.21	30	-46.5
Capital Expenditures	-173	-5.1	-6.08	-36.4	-22.6
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-84.7	-1.66	-0.259	-35.6	37.8
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities	-257	-6.76	-6.34	-71.9	15.2
Financing Cash Flow Items	-30	0.723	2.76	0.273	-6.25
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	78.4	1.81	-3.87	-4.26	-15.5
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-98.3	23.1	3.44	-41.9	-45.5